E2F in vivo binding specificity: Comparison of consensus versus nonconsensus binding sites

Genome Research

Volumn 18, Issue 11, 2008, Pages 1763-1777

  Rabinovich, Alina ^a   Jin, Victor X ^b   Rabinovich, Roman ^a   Xu, Xiaoqin ^a   Farnham, Peggy J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F4;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; DNA MICROARRAY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF;

3T3 CELLS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; DNA; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; HELA CELLS; HUMANS; MICE; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 55549103719     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.080622.108     Document Type: Article

References (57)

1. Acevedo, L.G., Iniguez, A.L., Holster, H.L., Zhang, X., Green, R., and Farnham, P.J. 2007. Genome-scale ChIP-chip analysis using 10,000 human cells. Biotechniques 43: 791-797.
2. Acevedo, L.G., Bieda, M., Green, R., and Farnham, P.J. 2008. Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors. Cancer Res. 68: 2641-2651.
3. Bandara, L.R., Buck, V.M., Zamanian, M., Johnston, L.H., and La Thangue, N.B. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12: 4317-4324.
4. Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., and Zhao, K. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
5. Bernstein, B.E., Meissner, A., and Lander, E.S. 2007. The mammalian epigenome. Cell 128: 669-681.
6. Bieda, M., Xu, X., Singer, M., Green, R., and Farnham, P.J. 2006. Unbiased location analysis of E2F1 binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 16: 595-605.
7. Carroll, J.S., Liu, X.S., Brodsky, A.S., Li, W., Meyer, C.A., Szary, A.J., Eeckhoute, J., Shao, W., Hestermann, E.V., Geistlinger, T.R., et al. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43.
8. Cawley, S., Bekiranov, S., Ng, H.H., Kapranov, P., Sekinger, E.A., Kampa, D., Piccolboni, A., Sementchenko, V., Cheng, J., Williams, A.J., et al. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116: 499-509.
9. Christensen, J., Cloos, P., Toftegaard, U., Klinkenberg, D., Bracken, A.P., Trinh, E., Heeran, M., Di Stefano, L., and Helin, K. 2005. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Nucleic Acids Res. 33: 5458-5470.
10. Conese, M., Auriche, C., and Ascenzioni, F. 2004. Gene therapy progress and prospects: Episomally maintained self-replicating systems. Gene Ther. 11: 1735-1741.
11. Cress, W.D., Johnson, D.G., and Nevins, J.R. 1993. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol. Cell. Biol. 13: 6314-6325.
12. de Bruin, A., Maiti, B., Jakoi, L., Timmers, C., Buerki, R., and Leone, G. 2003. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 278: 42041-42049.
13. DeGregori, J. and Johnson, D.G. 2006. Distinct and overlapping roles for E2F family members in transcription, proliferation, and apoptosis. Curr. Mol. Med. 6: 739-748.
14. DeGregori, J., Kowalik, T., and Nevins, J.R. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/S-regulatory genes. Mol. Cell. Biol. 15: 4215-4224.
15. Dennis, G.J., Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C., and Lempicki, R.A. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4: 3. doi: 10.1186/gb-2003-4-9- r60.
16. Di Stefano, L., Jensen, M.R., and Helin, K. 2003. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J. 22: 6289-6298.
17. Dimova, D.K. and Dyson, N.J. 2005. The E2F transcriptional network: Old acquaintances with new faces. Oncogene 24: 2810-2826.
18. Facchini, L.M., Chen, S., Marhin, W.W., Lear, J.N., and Penn, L.Z. 1997. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol. 17: 100-114.
19. Giangrande, P.H., Hallstrom, T.C., Tunyaplin, C., Calame, K., and Nevins, J.R. 2003. Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Mol. Cell. Biol. 23: 3707-3720.
20. Guenther, M.G., Levine, S.S., Boyer, L.A., Jaenisch, R., and Young, R.A. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88.
21. Halaban, R., Cheng, E., Zhang, Y., Mandigo, C.E., and Miglarese, M.R. 1998. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1 E132, but not by deletion of p16 INK4A or p21 WAF1/CIP1. Oncogene 16: 2489-2501.
22. Heintzman, N.D., Stuart, R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D., Barrera, L.O., Calcar, S.V., Qu, C., Ching, K.A., et al. 2007. Distinct predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39: 311-318.
23. Helin, K. and Harlow, E. 1994. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. J. Virol. 68: 5027-5035.
24. Helin, K., Wu, C.-L., Fattaey, A.R., Lees, J.A., Dynlacht, B.D., Ngwu, C., and Harlow, E. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes & Dev. 7: 1850-1861.
25. Hollenhorst, P.C., Shah, A.A., Hopkins, C., and Graves, B.J. 2007. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes & Dev. 21: 1882-1894.
26. Iyer, V.R., Horak, C.E., Scafe, C.S., Botstein, D., Snyder, M., and Brown, P.O. 2001. Genomic binding sites of the yeast cell-cycle transcription factor SBF and MBF. Nature 409: 533-538.
27. Jackson, D.A., Juranek, S., and Lipps, H.J. 2006. Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol. Ther. 14: 613-626.
28. Ji, H., Vokes, S.A., and Wong, W.H. 2006. A comparative analysis of genome-wide chromatin immunoprecipitation data for mammalian transcription factors. Nucleic Acids Res. 34: e146. doi: 10.1093/nar/gkl803.
29. Jin, V., Rabinovich, A., Squazzo, S.L., Green, R., and Farnham, P.J. 2006. A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data - A case study using E2F1. Genome Res. 16: 1585-1595.
30. Jin, V.X., O'Geen, H., Iyengar, S., Green, R., and Farnham, P.J. 2007. Identification of an OCT4 and SRY regulatory module using integrated computational and experimental genomics approaches. Genome Res. 17: 807-817.
31. Johnson, D.S., Li, W., Gordon, D.B., Bhattacharjee, A., Curry, B., Ghosh, J., Brizuela, L., Carroll, J.S., Brown, M., Flicek, P., et al. 2008. Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Res. 18: 393-403.
32. Karlseder, J., Rotheneder, H., and Wintersberger, E. 1996. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16: 1659-1667.
33. Kimura, K., Wakamatsu, A., Suzuki, Y., Ota, T., Nishikawa, T., Yamashita, R., Yamamoto, J., Sekine, M., Tsuritani, K., Wakaguri, H., et al. 2006. Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 16: 55-65.
34. Komashko, V.M., Acevedo, L.G., Squazzo, S.L., Iyengar, S.S., Rabinovich, A., O'Geen, H., Green, R., and Farnham, P.J. 2008. Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells. Genome Res. 18: 521-532.
35. Kong, L.-J., Chang, J.T., Bild, A.H., and Nevins, J.R. 2007. Compensation and specificity of function within the E2F family. Oncogene 26: 321-327.
36. Krek, W., Livingston, D.M., and Shirodkar, S. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262: 1557-1560.
37. Leung, J.Y., Ehmann, G.L., Giangrande, P.H., and Nevins, J.R. 2008. A role for Myc in facilitating transcription activation by E2F1. Oncogene 27: 4172-4179.
38. Li, J., Ran, C., Li, E., Gordon, F., Comstock, G., Siddiqui, H., Cleghorn, W., Chen, H.Z., Kornacker, K., Liu, C.G., et al. 2008a. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev. Cell 14: 62-75.
39. Li, X.-y., MacArthur, S., Bourgon, R., Nix, D., Pollard, D.A., Iyer, V.N., Hechmer, A., Simirenko, L., Stapleton, M., Luengo Hendriks, C.L., et al. 2008b. Transcription factors bind thousands of active and inactive regions in the Drosophila blastoderm. PLoS Biol. 6: e27. doi: 10.1371/journal.pbio.0060027.
40. Lieb, J.D., Liu, X., Botstein, B., and Brown, P.O. 2001. Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat. Genet. 28: 327-334.
41. Lindner, S.E. and Sugden, B. 2007. The plasmid replicon of Epstein-Barr virus: Mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid 58: 1-12.
42. Logan, N., Delavaine, L., Graham, A., Reilly, C., Wilson, J., Brummelkamp, T.R., Hijmans, E.M., Bernards, R., and La Thangue, N.B. 2004. E2F-7: A distinctive E2F family member with an unusual organization of DNA-binding domains. Oncogene 23: 5138-5150.
43. Logan, N., Graham, A., Zhao, X., Fisher, R., Maiti, B., Leone, G., and La Thangue, N.B. 2005. E2F-8: An E2F family member with a similar organization of DNA-binding domains to E2F-7. Oncogene 24: 5000-5004.
44. Maiti, B., Li, J., de Bruin, A., Gordon, F., Timmers, C., Opavsky, R., Patil, K., Tuttle, J., Cleghorn, W., and Leone, G. 2005. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 280: 18211-18220.
45. Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alverez, P., Brockman, W., Kim, T.-K., Koche, R.P., et al. 2007. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560.
46. O'Geen, H., Nicolet, C.M., Blahnik, K., Green, R., and Farnham, P.J. 2006. Comparison of sample preparation methods for ChIP-chip assays. Biotechniques 41: 577-580.
47. Oberley, M.J., Inman, D., and Farnham, P.J. 2003. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J. Biol. Chem. 278: 42466-42476.
48. Schlisio, S., Halperin, T., Vidal, M., and Nevins, J.R. 2002. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J. 21: 5775-5786.
49. Slansky, J.E. and Farnham, P.J. 1996. Introduction to the E2F family: Protein structure and gene regulation. In Transcriptional control of cell growth: The E2F gene family (ed. P.J. Farnham), pp. 1-30. Springer-Verlag, New York.
50. Tao, Y., Kassatly, R., Cress, W.D., and Horowitz, J.M. 1997. Subunit composition determines E2F DNA- binding site specificity. Mol. Cell. Biol. 17: 6994-7007.
51. Truscott, M., Harada, R., Vadnais, C., Robert, F., and Nepveu, A. 2008. p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes. Mol. Cell. Biol. 28: 3127-3138.
52. Weinmann, A.S., Yan, P.S., Oberley, M.J., Huang, T.H.-M., and Farnham, P.J. 2002. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes & Dev. 16: 235-244.
53. Wells, J., Boyd, K.E., Fry, C.J., Bartley, S.M., and Farnham, P.J. 2000. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell Biol. 20: 5797-5807.
54. Wells, J., Graveel, C.R., Bartley, S.M., Madore, S.J., and Farnham, P.J. 2002. The identification of E2F1-specific genes. Proc. Natl. Acad. Sci. 99: 3890-3895.
55. Wells, J., Yan, P.S., Cechvala, M., Huang, T., and Farnham, P.J. 2003. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sties during S phase. Oncogene 22: 1445-1460.
56. Wingender, E., Chen, X., Hehl, R., Karas, H., Matys, V., Meinhardt, T., Pruss, M., Reuter, I., and Schacherer, F. 2000. TRANSFAC: An integrated system for gene expression regulation. Nucleic Acids Res. 28: 316-319.
57. Xu, X., Bieda, M., Jin, V.X., Rabinovich, A., Oberley, M.J., Green, R., and Farnham, P.J. 2007. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals iterchangeable roles of E2F family members. Genome Res. 17: 1550-1561.